Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.06 USD | -2.75% | -10.17% | -2.75% |
05-09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Reports Q1 Revenue $1.4M, vs. Street Est of $1.36M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.75% | 200M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+48.71% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- LCTX Stock
- News Lineage Cell Therapeutics, Inc.
- Lineage Cell Therapeutics : Chardan Suspends Coverage on Lineage Cell Therapeutics at Buy Rating With $4 Price Target